Secretome Therapeutics
Dallas, US · Founded 2018 · Delaware corporation · 1 known investors
Founders & leadership
AS
ANGELA SHENNamed on SEC filing
HR
HENRIK RASMUSSENNamed on SEC filing
VJ
VINEET JINDALNamed on SEC filing
SK
SUNJAY KAUSHALNamed on SEC filing
WN
WILLIAM NILANDNamed on SEC filing
Investors · 1
Funding
SEC filings, press & company announcements$36.9M disclosed across 2 of 4 rounds · 2022–2026
- $30MSeries AMay 2026 · 3 sourcesSource ↗
▶$6.9MraisedFeb 2023 · 48 investors · BiotechnologyRule 506(b)
▶$6.9MraisedFeb 2023 · 48 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ANGELA SHENDirector
- HENRIK RASMUSSENDirector
- VINEET JINDALExecutive Officer, Director
- SUNJAY KAUSHALDirector
- WILLIAM NILANDDirector
- Offering amount
- $10.9M
- Amount sold
- $6.9M
- Minimum investment
- $1
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Secretome Therapeutics's investors?
- Secretome Therapeutics's investors include RA Capital.
- How much funding has Secretome Therapeutics raised?
- Secretome Therapeutics has disclosed $36.9M raised across 2 of its 4 known rounds.
- Where is Secretome Therapeutics headquartered?
- Secretome Therapeutics is headquartered in Dallas, US.